Eichenauer, Dennis A. and Engert, Andreas (2017). R-CHOP in NLPHL: who should receive it? Blood, 130 (4). S. 387 - 392. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Full text not available from this repository.Abstract
In this issue of Blood, Fanale and colleagues report promising treatment results for patients with newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) receiving R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) (see figure).
Item Type: | Journal Article | ||||||||||||
Creators: |
|
||||||||||||
URN: | urn:nbn:de:hbz:38-224651 | ||||||||||||
DOI: | 10.1182/blood-2017-05-786301 | ||||||||||||
Journal or Publication Title: | Blood | ||||||||||||
Volume: | 130 | ||||||||||||
Number: | 4 | ||||||||||||
Page Range: | S. 387 - 392 | ||||||||||||
Date: | 2017 | ||||||||||||
Publisher: | AMER SOC HEMATOLOGY | ||||||||||||
Place of Publication: | WASHINGTON | ||||||||||||
ISSN: | 1528-0020 | ||||||||||||
Language: | English | ||||||||||||
Faculty: | Unspecified | ||||||||||||
Divisions: | Unspecified | ||||||||||||
Subjects: | no entry | ||||||||||||
Uncontrolled Keywords: |
|
||||||||||||
Refereed: | Yes | ||||||||||||
URI: | http://kups.ub.uni-koeln.de/id/eprint/22465 |
Downloads
Downloads per month over past year
Altmetric
Export
Actions (login required)
View Item |